CtrlK
Day One Biopharmaceuticals
DAWN46
$7.71arrow_drop_down3.13%-$0.25
NASDAQ - As of Apr 4, 2:14 PM EDT Market Open
DAWN46
$7.71
arrow_drop_down3.13%Performance History
There's no data available for performance history chart
There's no data available for key stats
There's no data available for ratios/profitability stats
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Predicted: just now
info
Analyzed by 28 Wall Street experts, Day One Biopharmaceuticals's 12-month projections average at $39.85, spanning from a high of $54.00 to a low of $9.00. This signifies an 455.11% shift from the current price of $7.71.
Analyst Ratings
Buy
| Buy | 8 | 88.89% | |
|---|---|---|---|
| Hold | 1 | 11.11% | |
| Sell | 0 | 0.00% |
•Ratings from: April•
Last updated: just now
•Total: 9info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.
Correlated Companies
About Day One Biopharmaceuticals (DAWN)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Jeremy Bender M.B.A., Ph.D.
- Headquarters
- Brisbane
- Employees
- 124
- Exchange
- NASDAQ
Keep an eye on Day One Biopharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Day One Biopharmaceuticals's (DAWN) price per share?
The current price per share for Day One Biopharmaceuticals (DAWN) is $7.71. The stock has seen a price change of -$0.25 recently, indicating a -3.14% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Day One Biopharmaceuticals (DAWN)?
For Day One Biopharmaceuticals (DAWN), the 52-week high is $18.07, which is 134.22% from the current price. The 52-week low is $7.28, the current price is 5.98% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Day One Biopharmaceuticals (DAWN) a growth stock?
Day One Biopharmaceuticals (DAWN) has shown an average price growth of -1.65% over the past three years. It has received a score of 44 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Day One Biopharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Day One Biopharmaceuticals (DAWN) stock price performance year to date (YTD)?
As of the latest data, Day One Biopharmaceuticals (DAWN) has a year-to-date price change of -39.11%. Over the past month, the stock has experienced a price change of -6.48%. Over the last three months, the change has been -38.72%. Over the past six months, the figure is -44.09%.
help
Is Day One Biopharmaceuticals (DAWN) a profitable company?
Day One Biopharmaceuticals (DAWN) has a net income of -$95.5M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -223.68% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $131.16M, although specific revenue growth data is currently not available. The gross profit is $125.88M. Operating income is noted at -$217.27M. Furthermore, the EBITDA is -$210.71M.
help
What is the market capitalization of Day One Biopharmaceuticals (DAWN)?
Day One Biopharmaceuticals (DAWN) has a market capitalization of $781.44M. The average daily trading volume is 7.69, indicating the stock's liquidity and investor engagement.